AbbVie’s Alan Stevens discusses how companies can de-risk device development by working with regulators throughout the development process, and shares his perspective on connected devices, patient preferences and unmet needs.
Lead Editorial
![AbbVie’s Global Head of Complex Devices and Delivery Systems on Regulatory Challenges in New Delivery Device Approval](https://d38uvx7mib76ry.cloudfront.net/public/images/ruIHc9NgGT3SxlqTChpubwJj5k9TPAHYc6pScxtp.png)
AbbVie’s Alan Stevens discusses how companies can de-risk device development by working with regulators throughout the development process, and shares his perspective on connected devices, patient preferences and unmet needs.